@article{97d5ece436e34dde962181bef7751f12,
title = "Reply to: Major Clinical Trials Failed the Amyloid Hypothesis of Alzheimer's Disease",
author = "Eric McDade",
note = "Funding Information: Financial Disclosures: For Eli Lilly, Eric McDade provides continuing medical education sponsored by the Speaker{\textquoteright}s Bureau, is a member of the Data Safety Monitoring Board, and he is a nonsalaried cosponsor of solanezumab. He is also a nonsalaried cosponsor for gantenerumab for Roche. Funding Information: Financial Disclosures: For Eli Lilly, Eric McDade provides continuing medical education sponsored by the Speaker's Bureau, is a member of the Data Safety Monitoring Board, and he is a nonsalaried cosponsor of solanezumab. He is also a nonsalaried cosponsor for gantenerumab for Roche. Conflicts of Interest: Eric McDade has received personal compensation from Eli Lilly for continuing medical education and advisory board roles. He receives institutional support for clinical trials from Eli Lilly and Hoffman-la Roche. Author Contributions: Eric McDade was responsible for the development and preparation of the manuscript. Sponsor's Role: This work represents the personal opinion of Eric McDade; no sponsor was involved.",
year = "2019",
month = apr,
doi = "10.1111/jgs.15826",
language = "English",
volume = "67",
pages = "848--849",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
number = "4",
}